Abstract
Aim
The risk of excessive bleeding prompts physicians to discontinue aspirin in patients on low-dose, long-term therapy which in turn puts them at the risk from adverse cardiovascular and thrombotic events. Effect of low-dose aspirin therapy on platelet function was assessed using platelet aggregation method. The aim was to correlate the laboratory platelet function with cutaneous and clinical oral bleeding time (BT).
Materials and Methods
One hundred one patients were enrolled in this prospective trial and were allocated into two groups. Interventional or test group consisted of patients who were on aspirin therapy (75 mg/100 mg) for primary or secondary prevention of angina, myocardial infarction and stroke. Minor oral surgical procedure was performed in this group without discontinuing aspirin therapy. Control group consisted of healthy patients (under no medication) undergoing minor oral surgical procedure. Cutaneous and clinical oral BT were recorded in both the groups. Venous blood sample was drawn, and percentage platelet aggregation function was analysed using adenosine diphosphate (ADP) and arachidonic acid (AA) reagents. The percentage of platelet aggregation was then correlated with cutaneous and clinical oral BT.
Results
A significant decrease in percentage platelet aggregation using ADP (aspirin-74.7 21.39; control-89.2 13.70) and AA (aspirin-47.6 23.11; control-82.3 20.17) was observed. However, there were no significant difference in mean cutaneous BT (aspirin-1.5 0.65 min; control-1.6 0.71 min) and clinical oral BT (aspirin-5.0 2.48 min; control-4.8 2.60 min) in aspirin and control groups.
Conclusion
Majority of the minor oral surgical procedures can be carried out safely without discontinuing aspirin in patients on low-dose long-term therapy. This is possible because despite significant platelet aggregation evident in laboratory evaluation there is lack of its clinical corroboration owing to aspirin resistance.
Clinical Trial Registration
CTRI/2018/02/012055.
Similar content being viewed by others
References
De Caterina R, Lanza M, Manca G, Strata GB, Maffei S, Salvatore L (1994) Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 84(10):3363–3370
Gaspar R, Ardekian L, Brenner B, Peled M, Laufer D (1999) Ambulatory oral procedures in patients on low-dose aspirin. Harefuah 136(2):108–110
Medeiros FB, de Andrade AC, Angelis GA, Conrado VC, Timerman L, Farsky P et al (2011) Bleeding evaluation during single tooth extraction in patients with coronary artery disease and acetylsalicylic acid therapy suspension: a prospective, double-blinded, and randomized study. J Oral Maxillofac Surg 69(12):2949–2955
Canigral A, Silvestre FJ, Canigral G, Alos M, Garcia-Herraiz A, Plaza A (2010) Evaluation of bleeding risk and measurement methods in dental patients. Med Oral Patol Oral Cir Bucal. 15(6):e863–e868
Goodnough LT, Schrier ST (2014) Evaluation and management of anemia in the elderly. Am J Hematol 89(1):88–96
Le Blanc J, Lordkipanidzé M (2019) Platelet function in aging. Front Cardiovasc Med 6:109. https://doi.org/10.3389/fcvm.2019.00109
Collet J-P, Montalescot G (2006) Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. Eur Heart J Suppl 8(suppl_G):G46–G52
Ferrari E, Benhamou M, Cerboni P, Marcel B (2005) Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 45(3):456–459
Sibon I, Orgogozo JM (2004) Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 62(7):1187–1189
Collet JP, Himbet F, Steg PG (2000) Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 76(2–3):257–258
Collet JP, Montalescot G, Blanchet B, Tanguy ML, Golmard JL, Choussat R et al (2004) Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 110(16):2361–2367
Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27(22):2667–2674
Brennan MT, Valerin MA, Noll JL, Napenas JJ, Kent ML, Fox PC et al (2008) Aspirin use and post-operative bleeding from dental extractions. J Dent Res 87(8):740–744
Olin M (2000) Low-dose aspirin therapy. J Am Dent Assoc 131(10):1398–1401
Krishnan B, Shenoy NA, Alexander M (2008) Exodontia and antiplatelet therapy. J Oral Maxillofac Surg 66(10):2063–2066
Varghese KG, Manoharan S, Sadhanandan M (2015) Evaluation of bleeding following dental extraction in patients on long-term antiplatelet therapy: a clinical trial. Indian J Dent Res 26(3):252–255
Darawade DA, Kumar S, Desai K, Hasan B, Mansata AV (2014) Influence of aspirin on post-extraction bleeding—a clinical study. J Int Soc Prev Community Dent 4(Suppl 1):S63–S67
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A (2003) Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26(12):3264–3272
Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK et al (2007) Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 115(25):3156–3164
Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88:230–235
Brennan MT, Wynn RL, Miller CS (2007) Aspirin and bleeding in dentistry: an update and recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(3):316–323
Samson J, Mauprivez C, Alantar A, Perrin D, Tazi M (2004) Management of patients under anti-platelet agents’ treatment in odontostomatology. https://societechirorale.com/documents/Recommandations/recommandations_antiplaquettaires_gb.pdf. Accessed 14 Mar 2020
Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ et al (2007) Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115(6):813–818
Funding
Funding was provided by AIIMS JODHPUR (AIIMS/IEC/2015/485).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Consent to Publish
Authors are responsible for correctness of the statements provided in the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This submission has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.
Rights and permissions
About this article
Cite this article
Singh, S., Mandal, S., Chugh, A. et al. Clinical Post-operative Bleeding During Minor Oral Surgical Procedure and In Vitro Platelet Aggregation in Patients on Aspirin Therapy: Are they Coherent?. J. Maxillofac. Oral Surg. 20, 132–137 (2021). https://doi.org/10.1007/s12663-020-01438-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12663-020-01438-4